
Castle Creek Pharmaceutical Holdings to Acquire Exton-based Fibrocell for $63.3 Million
EXTON, PA — Fibrocell Science, Inc. (NASDAQ: FCSC), a cell and gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, announced it reached an agreement to …
Read More